US Stocks
/
Royalty Pharma plc Class A Share Price
Royalty Pharma plc Class A Share Price

Royalty Pharma plc Class A Share Price

NASDAQ: RPRX | Large Cap
$56.57
-$1.20 (-2.07%) Last updated on 14 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Royalty Pharma plc Class A Stock Performance

Open
$57.80
Prev. Close
$57.77
Circuit Range
N/A
Day Range
$56.43 - $57.84
Year Range
$35.24 - $64.37
Volume
1,20,572
Average Traded
$57.06

Royalty Pharma plc Class A Share Price Today

As of 14 October 2026, Royalty Pharma plc Class A's share price is $56.57. The stock opened at $57.80, compared to its previous close of $57.77. During today's trading session, Royalty Pharma plc Class A's share price traded between $56.43 and $57.84, with an average price of $57.13. Over the past 52 weeks, the stock has recorded a high of $64.37 and a low of $35.24. In terms of performance, Royalty Pharma plc Class A's share price has risen by 12.93% over the last six months and is up 50.63% on a year-on-year basis.

Royalty Pharma plc Class A Share Price Chart

$56.43$57.84
L
Show Current Price
H

Royalty Pharma plc Class A Stock Fundamentals & Key Indicators

Market Cap
$24.31B
PE Ratio (TTM)
31.57
Dividend Yield
1.55%
EPS (TTM)
$1.83
Revenue (TTM)
$2.38T
Return On Equity (TTM)
11.93%
Profit Margin
32.42%
Debt to Equity
1.33
Quarterly Earnings Growth YoY
-93.80%

Royalty Pharma plc Class A Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$609.29$621.99$630.58$674.14
Net Profit$288.22$214.21$294.69$17.88
Net Profit Margin47.30%34.44%46.73%2.65%
Income ChangeN/A-25.68%37.57%-93.93%

Royalty Pharma plc Class A Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$2237.22$2354.55$2263.58$2378.19
Net Profit$42.83$1134.83$858.98$770.95
Net Profit Margin1.91%48.20%37.95%32.42%
Income ChangeN/A2549.61%-24.31%-10.25%

About Royalty Pharma plc Class A

Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.

Royalty Pharma plc Class A Historical Returns

MonthOpenCloseChange %
Oct 2026
$58.26
$56.56
-3.14%
Sep 2026
$61.83
$58.40
-5.69%
Aug 2026
$57.97
$61.92
+5.98%
Jul 2026
$56.09
$58.42
+4.18%
Jun 2026
$55.16
$56.08
+0.57%
May 2026
$49.95
$55.76
+11.31%
Apr 2026
$48.19
$50.09
+4.43%
Mar 2026
$45.98
$47.97
+3.81%
Feb 2026
$41.53
$46.21
+10.91%
Jan 2026
$38.67
$41.66
+7.83%
Dec 2025
$40.15
$38.64
-3.51%
Nov 2025
$37.51
$40.05
+6.63%

RPRX Share Price FAQs

What is Royalty Pharma plc Class A share price today?

chevron-up
Royalty Pharma plc Class A share price today is $56.57 as on October 14, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Royalty Pharma plc Class A stock?

chevron-up
The 52 week high of Royalty Pharma plc Class A stock is $64.37, while the 52 week low is $35.24 as of 14 Oct '26.

What is RPRX's market capitalisation today?

chevron-up
RPRX market capitalisation is $24.31B as of October 14, 2026, at 10:11 am IST.

What is RPRX's net income for the last quarter?

chevron-up
RPRX's net income for the last quarter is 17.88B USD.

What is the 5 year returns of RPRX?

chevron-up
The 5 year returns of RPRX is 43.11% as on 14 Oct '26.

What is the high & low stock price of RPRX today?

chevron-up
RPRX stock price hit a high of $57.84 and low of $56.43 as of 14 Oct '26.

Can I buy RPRX shares in India?

chevron-up
Yes. You can buy RPRX in India by opening an international trading account.